IP Verse

Therapeutic Compositions Containing Macitentan

Patent No. EP3300729 (titled "Therapeutic Compositions Containing Macitentan") was filed by Actelion Pharmaceuticals on Aug 12, 2009. The application was issued on Oct 9, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKJul 9, 2020HGF
STADA ARZNEIMITTELJul 9, 2020HAMM & WITTKOPP
AERAJul 6, 2020AERA

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3300729

ACTELION PHARMACEUTICALS
Application Number
EP17191033A
Filing Date
Aug 12, 2009
Status
Revoked
Oct 14, 2024
Publication Date
Oct 9, 2019
External Links
Slate, Register , Google Patents